← Eichor
Study identifier: NCT06850311 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Herbal Ointment in Treating Atopic Dermatitis Topically

Condition: Atopic Dermatitis · Atopic Dermatitis (AD) · Atopic Dermatitis (Eczema)  ·  Sponsor: En Chu Kong Hospital

PhasePhase 2/Phase 3
Planned participants66
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Atopic dermatitis (AD), also known as atopic eczema, is a chronic inflammatory skin disorder. The current first-line recommended treatment for AD is the use of emollients, topical corticosteroids (TCS), and oral antihistamines if necessary. However, patients often have side effects like skin atrophy and telangiectasia. And there were plenty of herbal medicine which are beneficial to atopic dermatitis in ancient Chinese medicine books and records. Therefore, the purpose of this study is to develop a new topical application of traditional Chinese medicine and evaluate its clinical efficacy in AD patients. In human trial, 66 Subjects diagnosed as AD will be enrolled and treated with Sophora flavescens Aiton topical ointment. After treatment we will estimate the efficacy and record adverse events to conduct statistically analysis. The 1st year project: (1) Expect to enroll 66 clinical subjects of AD. (2) Evaluate subjects 'symptom and proceed herbal ointment treatment. (3) Record treatment responses including adverse effect. (4) Conduct statistically analysis. The 2nd year project: (1) Completing enrollment of 66 clinical subjects of AD. (2) Finish evaluation and treatment of all subjects. (3) Statistically analysis all collecting data (4) Discuss and analyze the outcome.

This description comes directly from the study's public registry record.

Talk to the study team

Ms. Chen  ·  886+(02)+27623456 #3118  ·  11759@km.eck.org.tw

Always discuss trial participation with your own doctor first.

Locations (1)

En Chu Kong hospitalNew Taipei City, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06850311